Deutsche Bank’s Sionna Therapeutics SION Stock Holding History

Deutsche Bank’s Portfolio SION Stock Details SION Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$88K	Sell	16,734 -36,619	-69%	-$841K	﹤0.01%	3396
2026 Q2	$2.35M	Buy	53,353 +40,104	+303%	+$1.6M	﹤0.01%	1813
2026 Q1	$531K	Buy	13,249 +3,220	+32%	+$123K	﹤0.01%	2546
2025 Q4	$413K	Buy	10,029 +433	+5%	+$16.4K	﹤0.01%	2670
2025 Q3	$282K	Hold	9,596	–	–	﹤0.01%	2884
2025 Q2	$166K	Buy	+9,596	New	+$126K	﹤0.01%	3052

Other funds holding SION

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Deutsche Bank's SION Position: Q3 2026 in Review

Deutsche Bank reduced its Sionna Therapeutics (SION) stake by 69% in Q3 2026, selling an estimated $841K and leaving 16,734 shares worth $88K. The position accounts for ﹤0.01% of the portfolio, ranked #3396.

Deutsche Bank first reported a position in SION in Q2 2025 and has held it in 6 quarters since. The position peaked at $2.35M in Q2 2026. 45 funds tracked by Wall St. Rank hold SION as of Q3 2026.

Deutsche Bank held 16,734 shares of Sionna Therapeutics worth $88K as of Q3 2026.
Deutsche Bank sold 36,619 Sionna Therapeutics shares in Q3 2026, an estimated $841K.
Sionna Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #3396 holding.
Deutsche Bank first reported a position in Sionna Therapeutics in Q2 2025 and has held it in 6 quarters since.
Deutsche Bank's Sionna Therapeutics position peaked at $2.35M in Q2 2026.
45 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.